Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $868.70 | 8 | 82.4% |
| Education | $184.94 | 2 | 17.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Eisai Inc. | $215.08 | 2 | $0 (2023) |
| Dendreon Pharmaceuticals LLC | $149.46 | 1 | $0 (2024) |
| Exelixis Inc. | $146.69 | 2 | $0 (2022) |
| Merck Sharp & Dohme LLC | $133.12 | 1 | $0 (2024) |
| Astellas Pharma US Inc | $124.99 | 1 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $99.95 | 1 | $0 (2023) |
| GENZYME CORPORATION | $99.36 | 1 | $0 (2022) |
| SANOFI-AVENTIS U.S. LLC | $84.99 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $282.58 | 2 | Dendreon Pharmaceuticals LLC ($149.46) |
| 2023 | $198.75 | 2 | AstraZeneca Pharmaceuticals LP ($99.95) |
| 2022 | $556.91 | 5 | Exelixis Inc. ($131.29) |
| 2021 | $15.40 | 1 | Exelixis Inc. ($15.40) |
All Payment Transactions
10 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/12/2024 | Merck Sharp & Dohme LLC | WELIREG (Drug) | Food and Beverage | In-kind items and services | $133.12 | General |
| Category: ONCOLOGY | ||||||
| 03/21/2024 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $149.46 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 06/14/2023 | Eisai Inc. | Lenvima (Drug) | Food and Beverage | Cash or cash equivalent | $98.80 | General |
| Category: Oncology | ||||||
| 02/22/2023 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Education | In-kind items and services | $99.95 | General |
| Category: Oncology | ||||||
| 12/08/2022 | GENZYME CORPORATION | — | Food and Beverage | In-kind items and services | $99.36 | General |
| 12/08/2022 | SANOFI-AVENTIS U.S. LLC | JEVTANA (Drug) | Education | In-kind items and services | $84.99 | General |
| Category: Oncology | ||||||
| 11/17/2022 | EISAI INC. | Lenvima (Drug) | Food and Beverage | Cash or cash equivalent | $116.28 | General |
| Category: Oncology | ||||||
| 05/12/2022 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: Oncology | ||||||
| 05/10/2022 | Exelixis Inc. | Cabometyx (Drug) | Food and Beverage | Cash or cash equivalent | $131.29 | General |
| Category: Oncology | ||||||
| 12/01/2021 | Exelixis Inc. | CABOMETYX (Drug) | Food and Beverage | In-kind items and services | $15.40 | General |
| Category: Oncology | ||||||
About Patrick Curran, NP
Patrick Curran, NP is a Oncology healthcare provider based in Boston, Massachusetts. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/06/2021. The National Provider Identifier (NPI) number assigned to this provider is 1023689510.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Patrick Curran, NP has received a total of $1,054 in payments from pharmaceutical and medical device companies, with $282.58 received in 2024. These payments were reported across 10 transactions from 8 companies. The most common payment nature is "Food and Beverage" ($868.70).
Practice Information
- Specialty Oncology
- Other Specialties Adult Health
- Location Boston, MA
- Active Since 07/06/2021
- Last Updated 09/13/2021
- Taxonomy Code 163WX0200X
- Entity Type Individual
- NPI Number 1023689510
Products in Payments
- Lenvima (Drug) $215.08
- PROVENGE (Drug) $149.46
- WELIREG (Drug) $133.12
- Cabometyx (Drug) $131.29
- Xtandi (Drug) $124.99
- LYNPARZA (Drug) $99.95
- JEVTANA (Drug) $84.99
- CABOMETYX (Drug) $15.40
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Oncology Doctors in Boston
Kaitlyn Chu, Np, NP
Oncology — Payments: $1,538
Ms. Marianne Tawa, Np, NP
Oncology — Payments: $1,176
Mr. Richard Boyajian, Anp, ANP
Oncology — Payments: $221.27
Lauren Sullivan, Rn, Agcns-Bc, RN, AGCNS-BC
Oncology — Payments: $121.86
Anne Elperin, M.s.n., N.p, M.S.N., N.P
Oncology
Mary Rapp, Np, NP
Oncology